SCHEMBL22708347

SCHEMBL22708347

c1ccc(-c2ccc3c(c2)c2c4oc5ccc6ccccc6c5c4ccc2n3-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 5/20 0.37
CYP1A1 P04798 4/20 0.37
CYP1A2 P05177 4/20 0.37
PAX8 Q06710 2/20 0.37
FYN P06241 1/20 0.37
MAPK3 P27361 1/20 0.37
AHR P35869 1/20 0.37
PGR P06401 1/20 0.34
NPC1 O15118 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
RAB9A P51151 1/20 0.32
CYP1B1 Q16678 3/20 0.32
ALDH1A1 P00352 3/20 0.32
HPGD P15428 3/20 0.32
TSHR P16473 3/20 0.32
KDM4E B2RXH2 2/20 0.32
MAPT P10636 2/20 0.32
HSD17B10 Q99714 2/20 0.32
PDE5A O76074 1/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22708632 0.94 ABCG2 (0.37) ABCG2CYP1A1CYP1A2PAX8FYN
SCHEMBL22708736 0.92 PGR (0.37) ABCG2CYP1A1CYP1A2PAX8FYN
SCHEMBL22893718 0.90 AHR (0.34) ABCG2CYP1A1CYP1A2PAX8FYN
SCHEMBL22893741 0.89 ABCG2 (0.37) ABCG2CYP1A1CYP1A2PAX8FYN
SCHEMBL22708379 0.89 CYP1A1 (0.38) ABCG2CYP1A1CYP1A2TDP1CYP1B1
SCHEMBL22893814 0.89 ABCG2 (0.38) ABCG2CYP1A1CYP1A2PAX8FYN
SCHEMBL14979596 0.88 ABCG2 (0.39) ABCG2CYP1A1CYP1A2PAX8FYN
SCHEMBL22893728 0.88 ABCG2 (0.34) ABCG2CYP1A1CYP1A2PAX8FYN
SCHEMBL14979509 0.88 ABCG2 (0.36) ABCG2CYP1A1CYP1A2PAX8FYN
SCHEMBL27324314 0.87 PLA2G2A (0.35) PGRALDH1A1HPGDTSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588110-B2 Heterocyclic compound and organic light emitting device comprising the same LT MATERIALS CO., LTD. (KR) 2023-02-21 US disclosed
US-20200373499-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LT MATERIALS CO., LTD. (KR) 2020-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11588110-B2 Heterocyclic compound and organic light emitting device comprising the same CRY1, CYP1A1, CYP1B1 ABCG2 2545/4885CYP1A1 2/4885CYP1A2 5/4885
US-20200373499-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, CYP1B1 ABCG2 2545/4885CYP1A1 2/4885CYP1A2 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.